[Optimal long-term use of proton pump inhibitors]
Tremblay E, Tardif M
Record ID 32017000005
French
Authors' recommendations:
Upon gathering information from good clinical practice recommendations and during multiple consultations, INESSS made the following observations:
• Prescribing PPIs is unwarranted in many cases.
• It will take more than clinical tools and training to change prescribing habits.
• One of the options for implementing the recommendations concerning the coverage of long-term PPI therapy could constitute a strategy for improving PPI use.
• The RAMQ confirms the feasibility of linking INESSS's clinical recommendations to one of the options for implementing the recommendations concerning PPI coverage in order to better guide PPI prescribing.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Avis_IPP_2016.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Lansoprazole
- Proton Pump Inhibitors
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
©Gouvernement du Québec/Institut national d'excellence en santé et en services sociaux
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.